Workgroup report: Biomonitoring study design, interpretation, and communication - Lessons learned and path forward

Environmental Health Perspectives

Volumn 113, Issue 11, 2005, Pages 1615-1621

  Bates, Michael N ^a   Hamilton, Joshua W ^b   LaKind, Judy S ^c,d,e   Langenberg, Patricia ^e   O'Malley, Michael ^f   Snodgrass, Wayne ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c LaKind Associates LLC   (United States)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Biomonitoring; Communication; Design; Human health; Interpretation; Specimen archiving

Indexed keywords

ARSENIC; CADMIUM; CHLORPYRIFOS; CHROMIUM; CIGARETTE SMOKE; ENVIRONMENTAL CHEMICAL; LEAD; MERCURY; PESTICIDE; PHTHALIC ACID; SALICYLIC ACID DERIVATIVE; TERT BUTYL METHYL ETHER;

ACCESS TO INFORMATION; AIR MONITORING; AIR POLLUTION; ARTICLE; BIOLOGICAL MONITORING; ENVIRONMENTAL EXPOSURE; HAIR ANALYSIS; HEALTH HAZARD; HUMAN; INDUSTRIAL WORKER; INFORMATION PROCESSING; INTERNET; MILK LEVEL; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REYE SYNDROME; RISK ASSESSMENT; SENSITIVITY ANALYSIS; TOXICOKINETICS; URINALYSIS; WATER CONTAMINATION;

COMMUNICATION; ENVIRONMENTAL HEALTH; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; HUMANS; RESEARCH DESIGN; RISK ASSESSMENT;

EID: 27744569046     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.8197     Document Type: Article

References (59)

1. Aitio A, Jarvisalo J. 1985. Biological monitoring of occupational exposure to toxic chemicals. Collection, processing, and storage of specimens. Ann Clin Lab Sci 15:121-139.
2. Albers JW, Berent S, Garabrant DH, Giordani B, Schweitzer SJ, Garrison RP, et al. 2004. The effects of occupational exposure to chlorpyrifos on the neurologic examination of central nervous system function: a prospective cohort study. J Occupational Environ Med 46:367-378.
3. American College of Medical Toxicology. 2005. Homepage. Fairfax, VA:American College of Medical Toxicology. Available: http://www.acmt.net/main/ [accessed 1 June 2005].
4. Andrew AS, Karagas MR, Hamilton JW. 2003a. Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water. Intl J Cancer 104:263-268.
5. Andrew AS, Karagas MR, Klei L, Hamilton JW. 2003b. Drinking water arsenic exposure is associated with decreased DNA repair gene expression. Toxicol Sci 72:184.
6. ATSDR. 2001. A Primer on Health Risk Communication Principles and Practices. Atlanta, GA:Agency for Toxic Substances and Disease Registry. Available: http://www.atsdr.cdc.gov/HEC/primer.html [accessed 29 March 2005].
7. ATSDR. 2005. Pediatric Environmental Health Specialty Units (PEHSU). Atlanta, GA:Agency for Toxic Substances and Disease Registry. Available: http://www.atsdr.cdc.gov/HEC/natorg/pehsu.html [accessed 23 September 2005].
8. Barrett S. 1985. Commercial hair analysis. Science or scam? JAMA 254:1041-1045.
9. Bates BA. 1998. Heavy metals and inorganic metals: mercury. In: Clinical Management of Poisoning and Drug Overdose (Haddad LM, Shannon MW, Winchester JF, eds). 3rd ed. Philadelphia:W.B. Saunders, 750-756.
10. Bernard A, Hermans C. 1997. Biomonitoring of early effects on the kidney or the lung. Sci Total Environ 199:205-211.
11. Braunwald E, Zipes DP, Libby P, eds. 2001. Heart Disease: A Textbook of Cardiovascular Medicine. 6th ed. Philadelphia: W.B. Saunders.
12. CDC. 2003. Second National Report on Human Exposure to Environmental Chemicals. Atlanta, GA:Centers for Disease Control and Prevention. Available: http://www.cdc.gov/exposurereport/ [accessed 29 March 2005].
13. CDISC (Clinical Data Interchange Standards Consortium). 2004. Homepage. Available: http://www.cdisc.org/ [accessed 23 September 2005].
14. CHEERS. 2005. Children's Environmental Exposure Research Study. Washington, DC:U.S. Environmental Protection Agency. Available: http://www.epa.gov/cheers/basic.htm [accessed 1 June 2005].
15. Christen WG. 2000. Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual? Arch Intern Med 160:422-434.
16. Essebag V, Genest J Jr, Suissa S, Pilote L. 2003. The nested case-control study in cardiology. Am Heart J 146:581-590.
17. Environmental Working Group. 2004. Group Demands Halt to Unethical, Scientifically Questionable Study in Which EPA and Chemical Industry Pay Families to Expose Children to Pesticides. Environmental Working Group Press Release. 29 October 2004. Available: http://www.ewg.org/issues/humantesting/20041029/index.php [accessed 29 March 2005].
18. Fischhoff B. 1995. Risk perception and communication unplugged: twenty years of progress. Risk Anal 15:137-145.
19. Forsyth BW, Horwitz RI, Acampora D, Shapiro ED, Viscoli CM, Feinstein AR, et al. 1989. New epidemiologic evidence confirming that bias does not explain the aspirin/Reye's syndrome association. J Am Med Assoc 261:2517-2524.
20. Goldman UR, Shannon MW, and the Committee on Environmental Health. 2001. Mercury in the environment: implications for pediatricians. Pediatrics 108:197-205.
21. Griffin RM. 1986. Biological monitoring for heavy metals: practical concerns. J Occup Med 28:615-618.
22. Helsel DR. 1990. Less than obvious - statistical treatment of data below the detection limit. Environ Sci Technol 24:1766-1774.
23. HIPAA. 1996. Health Insurance Portability and Accountability Act of 1996. Public Law 104-191. Available: http://aspe.hhs.gov/admnsimp/pl104191.htm [accessed 23 September 2005].
24. Huang Y-C. 2004. Lowering homocysteine levels does not reduce rates of stroke, coronary heart disease or death in people with ischaemic stroke. Evid Based Healthcare 8:210-212.
25. Kang SS, Wong PW, Cook HY, Norusis M, Messer JV. 1986. Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease. J Clin Invest 77:1482-1486.
26. Karagas MR, Le XC, Morris S, Blum JD, Lu X , Spate VL, et al. 2001a. Markers of low level arsenic exposure for evaluating human cancer risks in a US population. Int J Occup Med Environ Health 14:171-175.
27. Karagas MR, Morris JS, Weiss JE, Spate V, Baskett C, Greenberg ER. 1996. Toenail samples as an indicator of drinking water arsenic exposure. Cancer Epidemiol Biomarkers Prev 5:849-852.
28. Karagas MR, Stukel TA, Morris JS, Tosteson TD, Spencer SK, Greenberg ER. 2001b. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol 153:559-565.
29. Karagas MR, Tosteson TD, Morris JS, Demidenko E, Mott LA, Heaney J, et al. 2004. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control 15:465-472.
30. Karagas MR, Tosteson TD, Morris JS, Weiss JE, Stannard V, Spate VL, et al. 2000. Measurement of low levels of arsenic exposure: A comparison of water and toenail concentrations. Am J Epidemiol 152:84-90.
31. LaKind JS, ed. 2005. Technical Workshop on Human Milk Surveillance and Biomonitoring for Environmental Chemicals in the United States. J Toxicol Environ Health special issue Vol. 68, no. 20.
32. LaKind JS, Brent RL, Dourson ML, Kacew S, Koren G, Sonawane B, et al. 2005. Human milk biomonitoring data: interpretation and risk assessment issues. J Toxicol Environ Health 68(20):1713-1770.
33. LaKind JS, Wilkins AA, Berlin CM. 2004. Environmental chemicals in human milk: a review of concentrations, determinants, infant exposures and health, and guidance for future research. Toxicol Applied Pharmacol 198:184-208.
34. MMWR. 1991. Reye syndrome surveillance - United States, 1989. Morb Mortal Weekly Rep 40:88-90. Available: http://www.cdc.gov/mmwr/preview/mmwrhtml/00001906.htm [accessed 23 September 2005].
35. Nagayama J, Okamura K, Iida T, Hirakawa H, Matsueda T, Tsuji H, et al. 1998a. Postnatal exposure to chlorinated dioxins and related chemicals on thyroid hormone status in Japanese breast-fed infants. Chemosphere 37:1789-1793.
36. Nagayama J, Tsuji H, Iida T, Hirakawa H, Matsueda T, Okamura K, et al. 1998b. Postnatal exposure to chlorinated dioxins and related chemicals on lymphocyte subsets in Japanese breast-fed infants. Chemosphere 37:1781-1787.
37. Needham LL, Ryan JJ, Fürst P. 2002. Guidelines for analysis of human milk for environmental chemicals. J Toxicol Environ Health A 65:1893-1908.
38. Needham LL, Wang RY. 2002. Analytic considerations for measuring environmental chemicals in breast milk. Environ Health Perspect 110:A317-324.
39. Nichols TA, Morris JS, Mason MM, Spate VL, Beskett CK, Cheng TP, et al. 1998. The study of human nails as an intake monitor for arsenic using neutron activation analysis. J Radioanal Nucl Chem 236:51-56.
40. NIOSH. 2004. Specific Medical Tests or Examinations Published in the Literature for OSHA-Regulated Substances. NIOSH Pub. 2005-110. Huntington, WV:National Institute for Occupational Safety and Health. Available: http://www.cdc.gov/niosh/nmed/pdfs/2005-110.pdf [accessed 29 March 2005].
41. National Research Council. 1989. Improving Risk Communication. Washington, DC:National Academy Press.
42. Oleskey C, Fleischman A, Goldman L, Hirschhorn K, Landrigan PJ, Lappé M, et al. 2004. Pesticide testing in humans: ethics and public policy. Environ Health Perspect 112:914-919.
43. Pesticide Action Network Updates Service. 2004. Stop EPA From Testing Pesticides on Children. Available: http://www.panna.org/resources/panups/panup_20041201.dv.html [accessed 29 March 2005].
44. Sandman PM. 1990. Getting to maybe: some communications aspects of siting hazardous waste facilities. In: Readings in Risk (Glickman TS, Gough M, eds). Washington, DC: Resources for the Future, 233-246.
45. Schwartz LM, Woloshin S. 2004. The media matter: a call for straightforward medical reporting. Ann Intern Med 140:226-228.
46. Seidel S, Kreutzer R, Smith D, McNeel S, Gilliss D. 2001. Assessment of commercial laboratories performing hair mineral analysis. J Am Med Assoc 285:67-72.
47. SEND. 2004. Standard for Exchange of Nonclinical Data. Review Version 1.4 March 2, 2004. Available: http://www.cdisc.org/models/send/v1.4/ [accessed 23 September 2005].
48. Sexton K, Needham, LL, Pirkle JL. 2003. Human biomonitoring of environmental chemicals. Am Sci 92:38-45.
49. Steen LA. 1990. Numeracy. Daedalus 119:211-231. Available: http://www.stolaf.edu/people/steen/Papers/numeracy.html [accessed 29 March 2005].
50. Steindel SJ, Howanitz PJ. 2001. The uncertainty of hair analysis for trace metals. J Am Med Assoc 285:83-85.
51. Stokstad E. 2004. Pollution gets personal. Science 304:1892-1894.
52. U.S. EPA. 2005. Children's Environmental Exposure Research Study: this study was cancelled April 8, 2005. Washington, DC:U.S. Environmental Protection Agency. Available: http://www.epa.gov/cheers/ [accessed 12 April 2005].
53. Versieck J. 1985. Trace elements in human body fluids and tissues. Crit Rev Clin Lab Sci 22:97-184.
54. Waters MD, Fostel JM. 2004. Toxicogenomics and systems toxicology: aims and prospects. Nat Rev Genet 5:936-948.
55. Wax PM, Goldfarb A, Cernichiari E. 2000. Mercury contamination of heavy metal collection containers. Vet Hum Toxicol 42:22-25.
56. Wilson BW, Henderson JD, Ramirez A, O'Malley MA. 2002. Standardization of clinical cholinesterase measurements. Intl J Toxicol 21:385-388.
57. Woloshin S, Schwartz LM, Ellner A. 2003. Making sense of risk information on the web. Br Med J 327:695-696.
58. Woloshin S, Schwartz LM, Welsh HG. 2002. Risk charts: putting cancer risk in context. J Natl Cancer Inst 94:799-804.
59. Wright CB, Lee HS, Paik MC, Stabler SP, Allen RH, Sacco RL. 2004. Total homocysteine and cognition in a tri-ethnic cohort: the Northern Manhattan Study. Neurology 63:254-260.